Cover Image
市場調查報告書

胸部主動脈覆膜支架:醫療設備的開發平台評估

Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 358226
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
胸部主動脈覆膜支架:醫療設備的開發平台評估 Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月01日 內容資訊: 英文 76 Pages
簡介

本報告提供全球胸部主動脈覆膜支架市場上主要的開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品功能·特性比較分析 (臨床實驗的各進展階段) ,還有主要企業簡介及代表性產品,彙整近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 胸部主動脈覆膜支架概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 胸部主動脈覆膜支架的企業:各臨床實驗階段的開發中產品
  • 胸部主動脈覆膜支架:各臨床實驗階段的開發中產品

第5章 胸部主動脈覆膜支架市場:企業·產品概要

  • Cook Medical Incorporated
  • Evasc Medical Systems Corp.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • TriVascular, Inc.
  • W. L. Gore & Associates, Inc.

第6章 胸部主動脈覆膜支架市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2017" provides an overview of Thoracic Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thoracic Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Thoracic Aortic Stent Grafts Overview 6

3 Products under Development 7

  • 3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 7
  • 3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory 8
  • 3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path 9
  • 3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 10
  • 3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials 11

4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies 12

  • 4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 12
  • 4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 13

5 Thoracic Aortic Stent Grafts Companies and Product Overview 14

  • 5.1 Bolton Medical Inc Company Overview 14
    • 5.1.1 Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Cook Medical Inc Company Overview 16
    • 5.2.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Evasc Medical Systems Corp Company Overview 19
    • 5.3.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.4 Lombard Medical Technologies Inc. Company Overview 20
    • 5.4.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.5 Medtronic plc Company Overview 21
    • 5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.6 MicroPort Scientific Corp Company Overview 26
    • 5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.7 St. Jude Medical LLC Company Overview 29
    • 5.7.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.8 TriVascular Inc Company Overview 30
    • 5.8.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.9 W. L. Gore & Associates Inc Company Overview 31
    • 5.9.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 31

6 Thoracic Aortic Stent Grafts- Recent Developments 35

  • 6.1 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 35
  • 6.2 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 36
  • 6.3 Mar 30, 2017: MPSC Announces 2016 Annual Results 36
  • 6.4 Mar 20, 2017: MicroPort Endovascular Attends the Fifth Shangdong (Mount Tai) Aortic Surgery Forum 38
  • 6.5 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 38
  • 6.6 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 39
  • 6.7 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 40
  • 6.8 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 42
  • 6.9 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 43
  • 6.10 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 44
  • 6.11 Dec 30, 2016: MicroPort Endovascular Attends Sixth China Shenzhen International Cardiovascular Disease Forum & China Cardiovascular Surgery Technique and Engineering Conference 45
  • 6.12 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 45
  • 6.13 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 48
  • 6.14 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 49
  • 6.15 Nov 14, 2016: Medtronic to Unveil Data Supporting Endovascular Treatments for Aortic Disease at VEITHsymposium 2016 49
  • 6.16 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 52
  • 6.17 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 52
  • 6.18 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 53
  • 6.19 Sep 20, 2016: Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years 55
  • 6.20 Sep 19, 2016: First Implant Completed in Pivotal Study of GORE TAG Thoracic Branch Endoprosthesis 56
  • 6.21 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 57
  • 6.22 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 58
  • 6.23 Aug 30, 2016: MPSC Announces 2016 Interim Results 58
  • 6.24 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 60
  • 6.25 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 62
  • 6.26 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 63
  • 6.27 Jul 26, 2016: Merit Medical Announces Appointment of New Director 64
  • 6.28 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 64
  • 6.29 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 66
  • 6.30 Jun 21, 2016: FDA Approves Study of New Aneurysm Device Developed by Sanford Health 66
  • 6.31 Jun 08, 2016: First Patient Treated with Medtronic Valiant Evo Thoracic Stent Graft System 67
  • 6.32 Jun 08, 2016: Market-leading TEVAR Device is First to Surpass 100,000 Devices Distributed Worldwide 68
  • 6.33 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 69
  • 6.34 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 69

7 Appendix 73

  • 7.1 Methodology 73
  • 7.2 About GlobalData 76
  • 7.3 Contact Us 76
  • 7.4 Disclaimer 76

List of Tables

1.1 List of Tables

  • Table 1: Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 7
  • Table 2: Thoracic Aortic Stent Grafts - Pipeline Products by Territory 8
  • Table 3: Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path 9

List of Figures

1.2 List of Figures

  • Figure 1: Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 7
  • Figure 2: Thoracic Aortic Stent Grafts - Pipeline Products by Territory 8
  • Figure 3: Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path 9
  • Figure 4: Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 10
  • Figure 5: Thoracic Aortic Stent Grafts - Ongoing Clinical Trials 11
Back to Top